Prof. Dr. Muhammed Emin Akkoyunlu
Senior pulmonologist at Medipol Mega University Hospital. Expert in COPD, asthma, sleep medicine, lung cancer screening, and interventional bronchoscopy.
Credentials & Qualifications
Two decades of clinical excellence in internal medicine
- 2004 — Istanbul University, Faculty of Medicine — Subspecialty in Pulmonology
- 1998 — Istanbul University, Faculty of Medicine — Doctor of Medicine
- Turkish Board of Internal Medicine
- Medipol Mega University Hospital — Active Faculty
- International Internal Medicine Society Member
- Multiple peer-reviewed publications in internal medicine
- International conference presenter
- Mentor to fellowship trainees
- Patients from Middle East, Europe, Central Asia, and beyond
- Medipol's JCI-accredited international patient services
Professional Biography
Patient-centered internal medicine care at Medipol
Prof. Dr. Muhammed Emin Akkoyunlu is a senior pulmonologist at Medipol Mega University Hospital with 20 years of clinical experience. He is recognized for the comprehensive management of COPD, asthma, sleep disorders, and interstitial lung disease, alongside expertise in EBUS-guided bronchoscopy for lung cancer staging.
His practice emphasizes evidence-based, biologic-led asthma care, sleep apnea evaluation with home and lab studies, and structured smoking cessation. He runs an international lung cancer screening program with low-dose CT and same-week reporting for international patients.
Every breath should be effortless. My job is to find what is stealing your breath — and to give it back, with the gentlest treatment that works.
Surgical Specialties
Comprehensive internal medicine procedures using the latest techniques
COPD & Asthma Management
Comprehensive workup with spirometry, biologic therapy, and inhaler technique training.
Sleep Medicine & Apnea
Home sleep study, in-lab polysomnography, CPAP titration, and surgical referral when needed.
Interventional Bronchoscopy (EBUS)
Endobronchial ultrasound for lung cancer staging and central airway tumor management.
Lung Cancer Screening
Low-dose CT screening packages for international patients with same-week multidisciplinary review.
Interstitial Lung Disease
Pulmonary fibrosis, sarcoidosis, and connective tissue disease pulmonary care.
Smoking Cessation Program
Combined behavioral, pharmacologic, and follow-up support — 60%+ 12-month quit rates.
Patient Reviews
“Severe asthma uncontrolled for years. Biologic therapy with Prof. Akkoyunlu — life back to normal.”
Iraq
“Lung cancer screening package. Found a 6mm lesion early. Treated successfully. Lifesaver.”
UK
“Sleep apnea diagnosed and treated. CPAP fitting was excellent. Sleeping properly for the first time in years.”
Egypt
Frequently Asked Questions
What international patients ask before booking treatment
Either a home sleep test or in-lab polysomnography. Both are widely accepted; home is more comfortable.
Yes — annual low-dose CT for ages 50–80 with smoking history reduces lung cancer mortality by 20–30%.
2–3 days: imaging, blood work, consultation, and multidisciplinary report.
For severe eosinophilic or allergic asthma, biologics dramatically reduce attacks and oral steroid need.
An ultrasound-guided bronchoscopy that samples lymph nodes near the lungs without surgery — done under sedation.
Ready to consult Prof. Dr. Muhammed Emin Akkoyunlu?
Book your free consultation and take the first step with Prof. Dr. Muhammed Emin Akkoyunlu, a specialist in Internal Medicine.